June 2013 FDA Recall Drug by Hospira Inc.
D-608-2013 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Hospira Inc. on June 6, 2013 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-608-2013

Reason for Recall
Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.
Initiated
06-06-2013
Reported
06-26-2013
Quantity
676,872 containers

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide and Puerto Rico
0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-02

Batch or Lot Expiration Information

Lot# : 16-031-JT*, Exp 1APR2014; Note the * may be followed by 01 or 02